TV commercial highlights cortisol issues in type 2 diabetes

January 17, 2025

Corcept Therapeutics moves forward with a groundbreaking advertising campaign to increase awareness of Cushing’s by focusing on the results of recent research conducted by the company that shows that almost 25% of people with difficult-to-treat Type-2 diabetes may, in fact, have Cushing’s Syndrome, which could, also be the underlying cause of the diabetes.

Symptoms and signs of Cushing’s syndrome

August 2, 2016

This podcast is brought to you in part by a generous contribution from Corcept Therapeutics. From Lewis S Blevins Jr. MD – There is a wide spectrum of clinical presentations of patients with hypercortisolism, and in

Podcasts series on recurring Cushing’s disease

May 10, 2016

Pituitary World News podcast series on recurring Cushing’s disease is made possible in part by a generous grant from Corcept Therapeutics   This series covers the approaches, debates, evaluations, and the difficulties in diagnosis and managing

Cushing’s part 4: musings

May 10, 2016

This is the 4th podcast in our series on residual or recurring Cushing’s disease.  In part 4, Dr. Blevins shares additional information to empower patients to work with their physicians more effectively.     “Music: http://www.bensound.com/royalty-free-music

Cushing’s disease and IPSS.

November 27, 2015

From Lewis S Blevins, Jr. MD –  Ninety per-cent of ACTH-dependent causes of hypercortisolism are related to pituitary adenoma. The remaining 10% are related to ectopic, or non pituitary, sources of ACTH secretion. One-third of